IL-1BETA BINDING ANTIBODIES FOR USE IN TREATING CANCER

Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: THUREN, Tom, RIDKER, Paul, OTTEWELL, Penelope, LIGUEROS-SAYLAN, Monica, LAU, Yang Yi, LIBBY, Peter, DUGAN, Margaret, MATCHABA, Patrice
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Use of an IL-1β binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for the treatment and/or prevention of cancer with at least partial inflammatory basis.